See What the Data Room Won't Show. Verify Target Operations Before Capital Moves.

Private Equity Operational Due Diligence: The Exit Standard

Every private equity deal thesis rests on fundamental operational assumptions that traditional financial diligence fails to test. Msigma’s Kinetic Operations Model™ (KOM™) tests those assumptions directly—before capital moves, whether you are underwriting a new acquisition target or accelerating value creation across a long-held portfolio company.

Our non-permissive NPKA™ diagnostic evaluates target operational reality long before you gain virtual data room access. For active portfolio holdings, our cooperative PKA™ diagnostic pinpoints exactly where EBITDA is leaking and how much cash flow is recoverable prior to an exit process. Either way, the diagnostic read remains strictly deterministic and objective—never a deal partner's gut feel on a slide.

Schedule Consultation
an abstract photo of a curved building with a blue sky in the background

Read: The Private Equity Playbook

The Number Your Buyer Can't Dispute

The U.S. private-equity-backed portfolio backlog sits at roughly 13,325 unsold companies, representing over 8.7 years of inventory at current exit velocity (Source: PitchBook, Q1 2026). Furthermore, 52 percent of the global buyout portfolio has now been held for four years or longer (Source: McKinsey).

Multiple expansion is no longer rescuing aging fund returns. Buyers are only paying premium multiples for assets that can empirically prove real operational quality. Private equity sponsors sitting on stale assets require a defensible, objective operational read to bring to a buyer—not another subjective valuation opinion.

Deterministic Diagnostic Capabilities for Private Equity Sponsors

Pre-LOI Target Screening (NPKA™)

Portfolio EBITDA Recovery & Exit Positioning (PKA™)

Early Customer Health & Cash Flow Defensibility

  • Operational Mass™ (MΣ)

  • Uncover hidden workflow execution bottlenecks and capacity limits across target assets before submitting non-binding IOIs or entering exclusivity.

  • Market Resilience™ (MΩ)

  • Execute cooperative internal audits to isolate structural drag, eliminate leaked EBITDA, and establish an unassailable operational narrative for sell-side readiness.

  • Customer State™ (MΨ)

  • Audit underlying customer retention trajectory and pricing authority to ensure post-acquisition margin growth is durable under sponsor ownership.

Fortify Your Investment Thesis with Empirical Proof

Schedule a confidential operational due diligence consultation to learn how Msigma’s deterministic diagnostics support deal teams throughout target underwriting and sell-side exit preparation.

Schedule Consultation